Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1085 | 1085 | 1194 | 1051 | 1611 | 3123 |
Fund Return | 8.48% | 8.48% | 19.43% | 1.68% | 10% | 12.06% |
Place in category | 1658 | 1658 | 1316 | 1901 | 971 | 309 |
% in Category | 55 | 55 | 48 | 86 | 56 | 33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Baillie Gifford American Fund B Acc | 2.88B | 3.39 | -12.08 | 16.52 | ||
Baillie Gifford American Fund B Inc | 2.88B | 3.42 | -12.06 | 16.52 | ||
Baillie Gifford American Fund A Acc | 2.88B | 3.19 | -12.95 | 15.40 | ||
Baillie Gifford Global Alpha Growtb | 2.77B | 8.47 | 1.69 | 12.06 | ||
Baillie Gifford Pacific B Acc | 2.62B | -20.26 | 12.79 | 12.35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 15.17B | 9.59 | 8.81 | 15.94 | ||
Fundsmith Equity I Inc | 4.57B | 9.59 | 8.81 | 15.93 | ||
Fundsmith Equity R Acc | 593.68M | 9.43 | 8.16 | 15.23 | ||
Fundsmith Equity R Inc | 18.15M | 9.43 | 8.16 | 15.22 | ||
Fundsmith Equity T Acc | 4.13B | 9.56 | 8.70 | 15.82 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 4.12 | 501.80 | +1.54% | |
Martin Marietta Materials | US5732841060 | 3.83 | 587.27 | -0.95% | |
Microsoft | US5949181045 | 3.82 | 404.33 | -1.82% | |
Amazon.com | US0231351067 | 3.73 | 179.17 | -1.16% | |
Elevance Health | US0367521038 | 3.32 | 525.55 | +3.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review